Showing 1 - 8 results of 8 for search 'Brian L. Black', query time: 0.03s Refine Results
  1. 1
    NFATc1 Controls Skeletal Muscle Fiber Type and Is a Negative Regulator of MyoD Activity

    NFATc1 Controls Skeletal Muscle Fiber Type and Is a Negative Regulator of MyoD Activity by Melissa L. Ehlers, Barbara Celona, Brian L. Black

    Published 2014-09-01
    Get full text
    Article
  2. 2
    Venous endothelin modulates responsiveness of cardiac sympathetic axons to arterial semaphorin

    Venous endothelin modulates responsiveness of cardiac sympathetic axons to arterial semaphorin by Denise M Poltavski, Pauline Colombier, Jianxin Hu, Alicia Duron, Brian L Black, Takako Makita

    Published 2019-02-01
    Get full text
    Article
  3. 3
    Genomic analysis of transcriptional networks directing progression of cell states during MGE development

    Genomic analysis of transcriptional networks directing progression of cell states during MGE development by Magnus Sandberg, Leila Taher, Jianxin Hu, Brian L. Black, Alex S. Nord, John L. R. Rubenstein

    Published 2018-09-01
    Get full text
    Article
  4. 4
    Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE

    Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE by Christa Caggiano, Barbara Celona, Fleur Garton, Joel Mefford, Brian L. Black, Robert Henderson, Catherine Lomen-Hoerth, Andrew Dahl, Noah Zaitlen

    Published 2021-05-01
    Get full text
    Article
  5. 5
    Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106

    Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106 by Barbara Celona, John von Dollen, Sarat C Vatsavayai, Risa Kashima, Jeffrey R Johnson, Amy A Tang, Akiko Hata, Bruce L Miller, Eric J Huang, Nevan J Krogan, William W Seeley, Brian L Black

    Published 2017-01-01
    Get full text
    Article
  6. 6
    ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment

    ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment by Jeffrey D. Steimle, Chul Kim, Megan Rowton, Rangarajan D. Nadadur, Zhezhen Wang, Matthew Stocker, Andrew D. Hoffmann, Erika Hanson, Junghun Kweon, Tanvi Sinha, Kyunghee Choi, Brian L. Black, John M. Cunningham, Ivan P. Moskowitz, Kohta Ikegami

    Published 2023-06-01
    Get full text
    Article
  7. 7
    Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice

    Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice by Jeroen Overman, Frank Fontaine, Mehdi Moustaqil, Deepak Mittal, Emma Sierecki, Natalia Sacilotto, Johannes Zuegg, Avril AB Robertson, Kelly Holmes, Angela A Salim, Sreeman Mamidyala, Mark S Butler, Ashley S Robinson, Emmanuelle Lesieur, Wayne Johnston, Kirill Alexandrov, Brian L Black, Benjamin M Hogan, Sarah De Val, Robert J Capon, Jason S Carroll, Timothy L Bailey, Peter Koopman, Ralf Jauch, Matthew A Cooper, Yann Gambin, Mathias Francois

    Published 2017-01-01
    Get full text
    Article
  8. 8
    Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice

    Correction: Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice by Jeroen Overman, Frank Fontaine, Mehdi Moustaqil, Deepak Mittal, Emma Sierecki, Natalia Sacilotto, Johannes Zuegg, Avril AB Robertson, Kelly Holmes, Angela A Salim, Sreeman Mamidyala, Mark S Butler, Ashley S Robinson, Emmanuelle Lesieur, Wayne Johnston, Kirill Alexandrov, Brian L Black, Benjamin M Hogan, Sarah De Val, Robert J Capon, Jason S Carroll, Timothy L Bailey, Peter Koopman, Ralf Jauch, Matthew A Cooper, Yann Gambin, Mathias Francois

    Published 2023-08-01
    Get full text
    Article

Search Tools: